biote Corp. BTMD
Set alert
1.13 USD +0.02 +1.80%
At close · Nov 2
1.13 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
1.10 Day range 1.17
1.00 52-week range 2.98
- YTD
- -56.54%
- 1 year
- -60.63%
- Open
- 1.10
- Prev close
- 1.11
- Mkt cap
- 38.31M
- Vol
- 98.05K
- Avg vol
- 204.43K
- EPS
- 0.14
- P/E
- 8.07
- Div yield
- 0.00%
More statistics
- Low
- 1.10
- High
- 1.17
- Forward P/E
- 9.98
- Beta
- 0.00
- Short ratio
- 3.73
- Inst. own
- 64.60%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 5.88
- 200-d avg
- 6.21
- 1y target
- 9.95
5Y chart
Events in this range
- Jan 18, 2024Rating: Roth MKM · Buy → Buy
- Jan 18, 2024Rating: Truist Securities · Buy → Buy
- Feb 1, 2024Rating: Jefferies · — → Buy
- Feb 20, 2024Rating: B. Riley Securities · — → Buy
- Mar 12, 2024Earnings: —; estimate 0.08; surprise —%
- Mar 13, 2024Rating: Roth MKM · Buy → Buy
- May 7, 2024Earnings: 0.23; estimate 0.05; surprise 360%
- May 7, 2024Earnings: —; estimate 0.05; surprise —%
- Aug 8, 2024Earnings: 0.14; estimate 0.09; surprise 55.56%
- Aug 8, 2024Earnings: —; estimate 0.09; surprise —%
- Nov 12, 2024Earnings: 0.33; estimate 0.09; surprise 266.67%
- Dec 16, 2024Rating: Craig-Hallum · — → Buy
Signals (79)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| SMA: Bearish | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 13, 2026 | 6 months ago |
| RSI: Oversold | Mar 2, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 26, 2026 | 9 months ago |
| SMA: Bearish | Dec 22, 2025 | 10 months ago |
| SMA: Bullish | Dec 15, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 8, 2025 | 10 months ago |
| MACD: Sell Signal | Sep 15, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 8, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 11, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| SMA: Bullish | Jun 2, 2025 | 1 year ago |
| SMA: Bearish | May 26, 2025 | 1 year ago |
| MACD: Buy Signal | May 12, 2025 | 1 year ago |
| SMA: Bullish | May 5, 2025 | 1 year ago |
| RSI: Oversold | Apr 14, 2025 | 1 year ago |
| RSI: Oversold | Mar 10, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 20, 2025 | 1 year ago |
| SMA: Bearish | Jan 6, 2025 | 1 year ago |
| SMA: Bearish | Dec 16, 2024 | 1 year ago |
| SMA: Bullish | Nov 25, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 25, 2024 | 1 year ago |
| SMA: Bullish | Nov 18, 2024 | 1 year ago |
| SMA: Bearish | Nov 11, 2024 | 1 year ago |
| SMA: Bullish | Nov 4, 2024 | 1 year ago |
| SMA: Bearish | Aug 5, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 5, 2024 | 2 years ago |
| SMA: Bearish | Jul 29, 2024 | 2 years ago |
| SMA: Bullish | May 20, 2024 | 2 years ago |
| SMA: Bearish | May 13, 2024 | 2 years ago |
| SMA: Bullish | Apr 29, 2024 | 2 years ago |
| SMA: Bearish | Apr 15, 2024 | 2 years ago |
| SMA: Bullish | Feb 19, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 19, 2024 | 2 years ago |
| SMA: Bullish | Feb 12, 2024 | 2 years ago |
| SMA: Bearish | Dec 11, 2023 | 2 years ago |
| SMA: Bullish | Dec 4, 2023 | 2 years ago |
| SMA: Bearish | Nov 27, 2023 | 2 years ago |
| SMA: Bullish | Nov 20, 2023 | 2 years ago |
| SMA: Bearish | Nov 6, 2023 | 2 years ago |
| SMA: Bullish | Oct 30, 2023 | 3 years ago |
| SMA: Bearish | Oct 23, 2023 | 3 years ago |
| SMA: Bullish | Oct 2, 2023 | 3 years ago |
| SMA: Bearish | Aug 7, 2023 | 3 years ago |
| SMA: Bearish | Aug 7, 2023 | 3 years ago |
| MACD: Sell Signal | Aug 7, 2023 | 3 years ago |
| SMA: Bullish | Jun 12, 2023 | 3 years ago |
| MACD: Buy Signal | Jun 12, 2023 | 3 years ago |
| MACD: Sell Signal | Jun 5, 2023 | 3 years ago |
| SMA: Bearish | May 15, 2023 | 3 years ago |
| SMA: Bullish | Jan 23, 2023 | 3 years ago |
| SMA: Bullish | Jan 23, 2023 | 3 years ago |
| SMA: Bearish | Jan 16, 2023 | 3 years ago |
| SMA: Bullish | Jan 9, 2023 | 3 years ago |
| RSI: Oversold | Jan 2, 2023 | 3 years ago |
| SMA: Bearish | Oct 31, 2022 | 4 years ago |
| SMA: Bullish | Sep 19, 2022 | 4 years ago |
| SMA: Bearish | Sep 12, 2022 | 4 years ago |
| MACD: Buy Signal | Sep 5, 2022 | 4 years ago |
| SMA: Bullish | Aug 29, 2022 | 4 years ago |
| SMA: Bearish | Aug 22, 2022 | 4 years ago |
| SMA: Bullish | Aug 1, 2022 | 4 years ago |
| SMA: Bearish | May 23, 2022 | 4 years ago |
| RSI: Oversold | May 23, 2022 | 4 years ago |
| RSI: Overbought | May 16, 2022 | 4 years ago |
| SMA: Bullish | Mar 14, 2022 | 4 years ago |
| SMA: Bearish | Mar 7, 2022 | 4 years ago |
| SMA: Bullish | Feb 28, 2022 | 4 years ago |
| SMA: Bearish | Feb 21, 2022 | 4 years ago |
Key statistics
- Market cap
- 305.42M
- Enterprise value
- 287.07M
- Trailing P/E
- 19.30
- Forward P/E
- 9.98
- PEG ratio
- 0.00
- Price / sales
- 1.58
- Price / book
- 0.00
- EPS (TTM)
- 0.30
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 3.72%
- Revenue (TTM)
- 193.06M
- Revenue growth
- 12.80%
- Free cash flow
- 37.61M
- Total cash
- 38.23M
- Total debt
- 122.31M
- Return on equity
- 0.00%
- Shares outstanding
- 31.11M
- Short % of float
- 3.21%
- 50-day average
- 5.88
- 200-day average
- 6.21
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 9.95 +780.2% upside
Now 1.13
- Target (low)
- 8.00
- Target (mean)
- 9.95
- Target (high)
- 12.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 8, 2024
Expected Aug 8, 2024. Consensus EPS estimate 0.17.
Financials — quick view
BTMD Revenue — quarterly 44.23M
BTMD Net income — quarterly -6.56M
BTMD EPS — quarterly -0.23
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | 0.09 | 0.33 | +0.24 | +266.67% |
| Aug 8, 2024 | Jun 1, 2024 | 0.09 | 0.14 | +0.05 | +55.56% |
| Aug 8, 2024 | Jun 1, 2024 | 0.09 | — | — | — |
| May 7, 2024 | Mar 1, 2024 | 0.05 | 0.23 | +0.18 | +360.00% |
| May 7, 2024 | Mar 1, 2024 | 0.05 | — | — | — |
| Mar 12, 2024 | Dec 1, 2023 | 0.08 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 16, 2024 | Craig-Hallum | init | — | Buy |
| Mar 13, 2024 | Roth MKM | reit | Buy | Buy |
| Feb 20, 2024 | B. Riley Securities | init | — | Buy |
| Feb 1, 2024 | Jefferies | init | — | Buy |
| Jan 18, 2024 | Truist Securities | main | Buy | Buy |
| Jan 18, 2024 | Roth MKM | main | Buy | Buy |
About biote Corp.
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- biote.com
News
- Head-To-Head Survey: The Pennant Group (NASDAQ:PNTG) vs. biote (NASDAQ:BTMD)
- Biote Schedules Third Quarter 2026 Financial Results Release and Conference Call
- biote (NASDAQ:BTMD) and Elevance Health (NYSE:ELV) Head to Head Review
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- B. Riley Securities Maintains Neutral on Biote, Lowers Price Target to $1.5
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- biote Corp. (BTMD) Q2 2026 Earnings Call Transcript
- biote Corp. (BTMD) Reports Break-Even Earnings for Q2
- biote Q2 Earnings Call Highlights
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
Your note
Sign in to keep a note on BTMD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEER MARC D | Director | Sale | Jan 8, 2023 | 0 |
| CONE STEPHEN MARK | Director | Conversion of Exercise of derivative security | Jun 29, 2023 | 122,725 |
| CONLON MARY ELIZABETH | General Counsel | Sale | Jul 4, 2023 | 140,393 |
| HEYER ANDREW R | Director | Purchase | Jan 8, 2023 | 0 |
| JACOBY DANA LYNN | Director | Conversion of Exercise of derivative security | May 20, 2024 | 50,970 |
| KAMDAR SAMAR JAGAT | Chief Financial Officer | Purchase | Jan 8, 2023 | 13,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| 325 Capital Llc | 14.32% | 4,548,127 | 26.33M | Sep 29, 2024 |
| Bandera Partners LLC | 7.67% | 2,435,635 | 14.10M | Sep 29, 2024 |
| Blackrock Inc. | 5.44% | 1,725,875 | 9.99M | Sep 29, 2024 |
| Vanguard Group Inc | 4.47% | 1,417,793 | 8.21M | Sep 29, 2024 |
| Wasatch Advisors LP | 4.39% | 1,392,809 | 8.06M | Sep 29, 2024 |
| Dimensional Fund Advisors LP | 2.14% | 678,459 | 3.93M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.70% | 856,603 | 4.96M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.12% | 673,534 | 3.90M | Oct 30, 2024 |
| Wasatch Micro-Cap Value Fund | 1.93% | 613,010 | 3.55M | Sep 29, 2024 |
| RBB Fund Inc.- Boston Partners Small Cap Value Fd II | 1.56% | 493,862 | 2.86M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.08% | 342,071 | 1.98M | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 0.85% | 270,540 | 1.57M | Aug 30, 2024 |